ALKS Snapshot
Alkermes plc, a biopharmaceutical company, researches, develops and markets pharmaceutical products to address the unmet medical needs of patients in various therapeutic areas in the United States, Ireland and internationally. The company is headquartered in Dublin, Ireland.
Market Capitalization$4,902,810,000
Price to Sales4.08
Earnings per Share$-0.3810
PE RatioNone
Most Recent Close$29.3000
52 Week High$33
52 Week Low$21.24
50-Day Moving Average$27.84
200-Day Moving Average$26.99
All data are from Alpha Vantage as of today. For more infomation on ALKS see Stock Dividend, Valuation, Price and Financial Data for Investors